Clinical Trials
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
S2506
MOZART MZL: A Randomized Phase II Study with a Common Control Arm of Mosunetuzumab Monotherapy Evaluated Against Two Experimental Treatment Arms of Either Combination Mosunetuzumab and Zanubrutinib or Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients with Relapsed/Refractory Marginal Zone Lymphoma
Status Notes
Effective 08/18/2026, S2506 is open to accrual.
Research Committee(s)
Lymphoma
Activated
08-18-2026
ClinicalTrials.gov Registry Number
07638722
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
S1900N
A Randomized Phase II Study of Sacituzumab Govitecan alone, Ivonescimab alone, or Sacituzumab Govitecan and Ivonescimab in Participants with Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)
Status Notes
The above-referenced study will be open to participant accrual, effective 12:00 p.m. Pacific Time on August 3, 2026.
Research Committee(s)
LungMAP
Activated
08-03-2026
ClinicalTrials.gov Registry Number
07393555
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
MM1OA-S04
A Phase 2 trial of ASTX727 with standard duration versus shorter duration of venetoclax in genomically heterogenous AML among adults aged 60 or older and less fit for intensive therapy: a myeloMATCH substudy.
Research Committee(s)
myeloMATCH
Activated
07-22-2026
ClinicalTrials.gov Registry Number
NCT07437950
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
S2505
Phase III Randomized Study Testing Non-Inferiority of Short-Course Ultra-Hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) for Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma
Status Notes
Effective 7/6/2026 S2505 is active.
Research Committee(s)
Early Therapeutics & Rare Cancers
Activated
07-06-2026
ClinicalTrials.gov Registry Number
07615049
Open
Phase
Accrual
1%
SWOG Clinical Trial Number
S2504
A Randomized Phase III Study of PIRtobrutinib plus R-CHOP vs. R-CHOP for Patients with Previously UntreateD RIchter TrAnsforMation (RT) (pirAMID)
Status Notes
Study is active as of 06/01/2026.
Research Committee(s)
Leukemia
Lymphoma
Activated
06-01-2026
ClinicalTrials.gov Registry Number
07220187
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
S2424CD
A Randomized Controlled Trial of an Intervention called Algorithm-Enabled Patients Activated in Cancer Care through Teams (A-PACT) to Improve Goals of Care Communication for People with Cancer
Status Notes
Activation 06/01/2026
Research Committee(s)
Cancer Care Delivery
Activated
06-01-2026
ClinicalTrials.gov Registry Number
07278739